Clinical trial
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
NCT01744496 is registered in ClinicalTrials.gov with UCB BIOSCIENCES GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
- Lead sponsor
- UCB BIOSCIENCES GmbH
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- January 31, 2014
- Enrollment
- 68 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
advanced idiopathic parkinson's disease